Inactive Instrument

Company Star Scientific, Inc. Nasdaq

US85517P1012

Pharmaceuticals

End-of-day quote Nasdaq
- ^USD	-

20-12-07	Rock Creek Pharmaceuticals, Inc. Went Out of Business	CI
20-02-05	Bankruptcy Judge Changed for Rock Creek Pharmaceuticals, Inc.	CI

Business description: Star Scientific, Inc.

Rock Creek Pharmaceuticals Inc is a United States-based pharmaceutical development company. The Company is focused on the discovery, development and commercialization of therapies for chronic inflammatory disease and neurologic disorders. Its activities are focused on its lead compound, anatabine citrate (anatabine). Anatabine is a small molecule, cholinergic agonist, which exhibits anti-inflammatory pharmacological characteristics. The Company focuses on dermatological skin diseases, such as psoriasis, eczema and rare or orphan skin disorders, using its formulations of anatabine.

Company details: Star Scientific, Inc.

Rock Creek Pharmaceuticals, Inc.

2040 Whitfield Avenue

34243, Sarasota

+844-727-0727

https://rockcreekpharmaceuticals.com

Other Pharmaceuticals

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ELI LILLY AND COMPANY	-0.88%	-2.15%	+54.71%	+106.31%	1,024B
JOHNSON & JOHNSON	-1.15%	+2.68%	+53.97%	+71.50%	663B
ABBVIE INC.	-1.44%	+0.38%	+20.40%	+73.05%	453B
ROCHE HOLDING AG	+0.14%	-0.47%	+29.49%	+38.56%	352B
NOVARTIS AG	-1.33%	+4.72%	+24.69%	+45.55%	304B
ASTRAZENECA PLC	-1.15%	+0.30%	-1.49%	+12.31%	252B
AMGEN INC.	-1.55%	+1.11%	+56.10%	+70.32%	236B
NOVO NORDISK A/S	-0.88%	+1.15%	-17.09%	-54.39%	206B
GILEAD SCIENCES, INC.	-0.15%	+3.65%	+33.90%	+96.99%	187B
Average	-0.99%	+1.09%	+28.30%	+51.13%	408.71B
Weighted average by Cap.	-1.10%	+0.55%	+36.62%	+66.22%